http://wherehopegrows.org - Prostate cancer patient Eddie Wright and medical oncologist, Douglas J. Thompson, MD. tell us about the new FDA-approved Provenge vaccine treatment for metastatic prostate cancer. The treatment process uses the patient's own altered white blood cells to fight prostate cancer. The treatment has almost none of the side effects of chemotherapy, since the vaccine is generated from the patient's own cells. Provenge is being offered throught the Cancer Center at Blue Ridge HealthCare's Grace Hospital in Morganton, NC.
1. Provenge offers an improved median survival time of 4.5 months. Half of the patients in the Provenge study (trial) lived longer!!!
2. In the past 30+ years, only one therapy was available for men and that was a poisonous chemotherapy regimen called Taxotere (by Sanofi Aventis).
3. Provenge will change the way cancer is treated!
ThankYou
acap2224 7 months ago